Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19

BACKGROUND: Neutralizing monoclonal antibodies (MAbs) are a promising therapy for early coronavirus disease 2019 (COVID-19), but their effectiveness has not been confirmed in a real-world setting. METHODS: In this quasi-experimental pre-/postimplementation study, we estimated the effectiveness of MA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Forum Infect Dis
Asıl Yazarlar: Webb, Brandon J, Buckel, Whitney, Vento, Todd, Butler, Allison M, Grisel, Nancy, Brown, Samuel M, Peltan, Ithan D, Spivak, Emily S, Shah, Mark, Sakata, Theadora, Wallin, Anthony, Stenehjem, Eddie, Poulsen, Greg, Bledsoe, Joseph
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2021
Konular:
Major Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314951/
https://ncbi.nlm.nih.gov/pubmed/34327256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab331
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller